Ridgeback Capital

Ridgeback Capital is an actively managed private investment company that specializes in both securities trading and long-term private investment, with a specialized focus on investing in life science companies. Ridgeback was started in 2006 by Wayne Holman, MD. Dr. Holman and his team seek investments in private and public companies that are creating life-saving and life changing technologies.

 
 
rcap_banner_2020.jpg
 
 

Our Philosophy

Ideal investments candidates are ideas, technologies and companies that will make a difference. We believe that behind every great advance there are a team of people who made it happen. The long term nature of our private investment capital, separate from our securities trading platform, gives us huge flexibility and allows us to support these innovators and help fund important change

 
RidgeBackCap_investments.png
 

Select Investments

 
 
 

About our founder

Makers of change. Investors in humanity.

 

Dr. Wayne Holman, the CEO and Founder of Ridgeback Capital, is a licensed physician and graduate of New York University School of Medicine with an undergraduate degree in economics from Yale University. Additionally, he is the co-founder of Ridgeback Biotherapeutics and serves as Co-Chair of the Ridgeback-Merck Molnupiravir Joint Steering Committee. He also serves as a member of the NYU Langone Board of Trustees and the University of Miami Board of Trustees. With a track record spanning over two decades, Dr. Holman has contributed funding to over 100 public and private biopharma companies, supporting the research and development of transformative medicines to address unmet needs. Residing in Miami, he shares his home with his wife, four children, and three dogs.

Ridgeback Capital was founded in 2006 and is focused on healthcare investments. Ridgeback invests in private and public companies that are dedicated to the development of life saving and life changing therapies.  Healthcare advances take many years to materialize and Dr. Wayne Holman believes that patient capital is vital for new technologies and companies to thrive.

More about the team.

 
 
Coco_Ridgeback_Cap.png
 

Our Namesake

Ridgeback Capital is named after our founder’s Rhodesian Ridgeback Coco. Coco was rescued from an animal shelter. For, over a decade, she happily thrived and was proud to be the namesake of Ridgeback Capital. Somewhat analogous to building a great company, Coco’s story is an excellent reminder that all good outcomes require thoughtful people who make great decisions.

 
 
Bg.png
 
 
ridgebackcap_logo.png

info@ridgebackcap.com | 212-624-2600

348 West 14th Street, New York, NY, 10014

 
Bg.png